Published in

Springer Nature [academic journals on nature.com], British Journal of Cancer, 6(129), p. 895-896, 2023

DOI: 10.1038/s41416-023-02194-1

Links

Tools

Export citation

Search in Google Scholar

Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination

Journal article published in 2023 by Francesco Pasqualetti ORCID, Sofia Zanotti
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

SummaryRecently, Liau et al. reported the results of Phase 3 clinical trial testing DCVax-L vaccines on patients with glioblastoma. Despite the promising and significant results obtained, the study design and the long-lasting period of recruitment of this work deserve some reflection.